Diabetes Panel - Ayass Bioscience, LLC

Diabetes Panel

Why It Matters

The Diabetes Panel provides a broader view of blood sugar control and metabolic health than a single glucose measurement alone. By combining long-term glucose trends with insulin evaluation, it can identify insulin resistance and pre-diabetes before more serious complications develop. Early detection supports timely intervention and better long-term health outcomes.

Who Should Get It

Recommended for individuals with family history of diabetes, obesity, metabolic syndrome, PCOS, unexplained fatigue, weight changes, or elevated blood sugar. It is also useful for monitoring patients with pre-diabetes or diabetes and evaluating metabolic health over time.

How This Panel Is Used

Physicians use the Diabetes Panel to assess long-term glucose control, detect insulin resistance, monitor response to treatment, and guide lifestyle or medication decisions. It is commonly ordered during preventive screenings, metabolic evaluations, and ongoing diabetes management.

What’s Included

This panel includes biomarkers associated with long-term glucose control, insulin activity, and metabolic regulation, providing a more complete picture of blood sugar trends and early insulin resistance. Together, these markers help identify pre-diabetes, monitor diabetes management, and support personalized metabolic care.

HbA1c (Hemoglobin A1c)

This test measures the percentage of glucose bound to hemoglobin, reflecting average blood sugar levels over the past 2–3 months.

Diagnostic Value: HbA1c is the primary test for diagnosing and monitoring diabetes and prediabetes.

Clinical Significance: Elevated HbA1c indicates poor long-term glucose control and a higher risk of complications such as neuropathy, nephropathy, and cardiovascular disease.

Symptom Correlation: Patients may experience fatigue, increased thirst, or frequent urination, though early stages often present without symptoms.

The HbA1c test provides a stable, long-term measure of blood sugar control unaffected by daily fluctuations.

Insulin

This test measures the level of insulin — the hormone responsible for moving glucose from the bloodstream into cells for energy.

Diagnostic Value: Insulin testing helps detect insulin resistance, type 2 diabetes, and certain metabolic or endocrine disorders.

Clinical Significance: High insulin levels can signal insulin resistance or early type 2 diabetes, while low levels may indicate type 1 diabetes or pancreatic dysfunction.

Symptom Correlation: Patients may report fatigue, hunger, weight changes, or difficulty managing blood sugar levels.

eAG (Estimated Average Glucose)

This test converts HbA1c results into an estimated daily average glucose level for easier interpretation.

Diagnostic Value: eAG expresses long-term glucose control in the same units as daily glucose readings (mg/dL), making results more understandable for both patients and clinicians.

Clinical Significance: eAG helps visualize overall glucose trends, supporting consistent monitoring and treatment adjustments.

Symptom Correlation: Patterns of elevated eAG correlate with sustained hyperglycemia and increased risk of diabetic complications.

The eAG test translates long-term data into clear, actionable insight for effective diabetes management.

The Insulin test helps uncover metabolic imbalance before glucose levels become abnormal.

Together, these biomarkers provide a comprehensive view of glucose regulation and metabolic health, supporting early detection, risk assessment, and informed clinical decision-making.